November 23, 2015
CERENIS’ FLAGSHIP PRODUCT NAMED ONE OF 2015’S MOST PROMISING CARDIOVASCULAR PROJECTS AT THE AMERICAN “THERAPEUTIC AREA PARTNERSHIPS” (TAP) CONFERENCE
Media
November 18, 2015
Targovax ASA: LUDWIG CANCER RESEARCH AND CANCER RESEARCH INSTITUTE PARTNER WITH TARGOVAX TO TEST CANDIDATE VIROTHERAPY IN EARLY-PHASE CLINICAL TRIALS
November 13, 2015
NORDIC NANOVECTOR ANNOUNCES RESIGNATION OF CHIEF MEDICAL OFFICER
November 12, 2015
Cash position and revenue for Q3 2015
November 10, 2015
New Data for CER-001 presented in key Oral Session at AMERICAN HEART ASSOCIATION (AHA) CONFERENCE 2015
November 05, 2015
Targovax ASA: Immunotherapy with ONCOS-102 show potential to activate immunologically silent tumors and reduce local immune suppression in advanced tumors
November 03, 2015
Strongbridge Biopharma plc Announces Data Presentation at the Society for Endocrinology BES 2015 Conference
November 03, 2015
CER-001: Analysis of clinical results to be presented at the American Heart Association Scientific Congress, on November 9, 2015 in Orlando, UNITED-STATES
November 02, 2015
Wilson Therapeutics Appoints Anders Martin-Löf as Chief Financial Officer
October 30, 2015
NORDIC NANOVECTOR TO HOST CAPITAL MARKETS DAY IN OSLO ON 17 NOVEMBER 2015
